Free Trial

Trevi Therapeutics (TRVI) Insider Trading & Ownership

Trevi Therapeutics logo
$6.99 +0.09 (+1.30%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$7.06 +0.08 (+1.07%)
As of 05/2/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Trevi Therapeutics (NASDAQ:TRVI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.37%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$932,610.25
Get TRVI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TRVI Insider Buying and Selling by Quarter

Trevi Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2025Jennifer L GoodCEOSell5,263$6.58$34,630.54  
3/10/2025Farrell SimonInsiderSell81,313$6.75$548,862.75  
9/9/2024Jennifer L GoodCEOSell1,840$3.04$5,593.60  
9/6/2024Jennifer L GoodCEOSell4,219$3.03$12,783.57  
9/4/2024Jennifer L GoodCEOSell10,981$3.02$33,162.62  
8/27/2024David P MeekerDirectorSell4,555$2.93$13,346.15  
8/16/2024Thomas SciasciaInsiderSell18,660$2.76$51,501.60  
8/14/2024Thomas SciasciaInsiderSell100$2.75$275.00  
5/29/2024Thomas SciasciaInsiderSell53,368$2.55$136,088.40  
5/22/2024Lisa DelfiniCFOSell4,350$2.64$11,484.00  
5/20/2024Jennifer L GoodCEOSell25,037$2.86$71,605.82  
5/10/2024Jennifer L GoodCEOSell4,578$2.90$13,276.20  
(Data available from 1/1/2013 forward)

TRVI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Trevi Therapeutics includes David P Meeker, Farrell Simon, Jennifer L Good, Lisa Delfini, Thomas Sciascia, and Tpg Gp A, Llc. Learn more on insiders at TRVI.

24.37% of Trevi Therapeutics stock is owned by insiders. Learn more on TRVI's insider holdings.

The following insiders have sold TRVI shares in the last 24 months: David P Meeker ($13,346.15), Farrell Simon ($548,862.75), Jennifer L Good ($171,052.35), Lisa Delfini ($19,461.40), and Thomas Sciascia ($187,865.00).

Insiders have sold a total of 217,739 Trevi Therapeutics shares in the last 24 months for a total of $940,587.65 sold.

Trevi Therapeutics Key Executives



This page (NASDAQ:TRVI) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners